Replicating viruses as selective cancer therapeutics (Q41335851)

29 September 2017

1 reference

title

Replicating viruses as selective cancer therapeutics (English)

1 reference

29 September 2017

Kirn DH

1

1 reference

29 September 2017

McCormick F

series ordinal

2

1 reference

29 September 2017

publication date

1 December 1996

1 reference

Trends in Molecular Medicine

29 September 2017

published in

1 reference

29 September 2017

volume

2

1 reference

29 September 2017

issue

12

1 reference

29 September 2017

page(s)

519-527

1 reference

VIRUSES IN THE TREATMENT OF CANCER

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Studies on the use of viruses in the treatment of carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Treatment of human cancer with mumps virus

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Immunology taught by viruses

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Retroviral vectors displaying functional antibody fragments

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Antineoplasic activity of parvoviruses

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Selective destruction of gliomas in immunocompetent rats by thymidine kinase-defective herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Newcastle disease virus selectively kills human tumor cells

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Parvovirus H-1 inhibits growth of short-term tumor-derived but not normal mammary tissue cultures

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein.

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Cytolysis of adenovirus-infected murine fibroblasts by IFN-gamma-primed macrophages is TNF- and contact-dependent

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

1 reference

https://api.crossref.org/works/10.1016/S1357-4310(97)81456-6

7 January 2021

10.1016/S1357-4310(97)81456-6

Identifiers

DOI

1 reference

29 September 2017

1 reference